Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function—value of the wearable cardioverter/defibrillator

摘要: Aims The true incidence of life-threatening ventricular tachyarrhythmic events and the risk sudden cardiac death in early stage peripartum cardiomyopathy (PPCM) are still unknown. We aimed to assess usefulness wearable cardioverter/defibrillator (WCD) bridge a potential for arrhythmic patients with PPCM, severely reduced left ejection fraction (LVEF) symptoms heart failure. Methods results Twelve consecutively admitted women PPCM were included this single-centre, prospective observational study between September 2012 2013. Patients LVEF ≤35% considered use WCD 3 months or even 6 when necessary recovery. Nine 12 had (mean 18.3%) at time enrolment; seven received WCD, while two refused wear WCD. During median follow-up 81 days (range 25–345 days), we observed total four fibrillation appropriate successful shocks three receiving No syncope deaths occurred not using during 5–15 months). All showed impressive improvement follow-up. Conclusion PPCM have an elevated tachyarrhythmias after diagnosis. Therefore, should be all early-stage first initiation failure therapy.